Interface 20 Micron Transfusion Bld F
Abbott Laboratories
FDA Clearance Information
The Interface 20 Micron Transfusion Bld F was cleared through the FDA 510k pathway on April 21, 1981. Manufactured by Abbott Laboratories, it is classified as a Class 2 device under product code CAK.
What It Is
FDA-Cleared Indications
- Filtration of blood and blood components during transfusion.
- Removal of microaggregates and particulate matter from transfused blood products.
- Use as part of a compatible blood-transfusion administration set.
Clinical Applications
- Filtering whole blood during transfusion.
- Filtering red blood cell components during transfusion.
- Filtering platelet components when compatible with the labeled transfusion setup.
- Use in hospital transfusion services and hematology settings where particulate filtration is indicated.
Practical Considerations
- The device uses a 20-micron filter and should be used only with compatible blood products, tubing, and administration equipment.
- Prime the filter and tubing according to the instructions for use and institutional protocol to reduce air entry and maintain appropriate flow.
- Inspect the filter, package, connections, and expiration date before use; do not use if damaged or contaminated.
- Monitor flow, pressure, clotting, leakage, and patient response during transfusion. Replace the set according to the labeling and blood-bank policy rather than reusing it.
- This is not an implantable device and has no MRI-related implant safety designation; MRI compatibility is generally not relevant after the external transfusion setup is removed.
Frequently Asked Questions
What is Interface 20 Micron Transfusion Bld F used for?
It is used to filter blood products during transfusions, removing microaggregates and contaminants to ensure patient safety.
What specialties typically use this device?
Hematology and transfusion medicine specialists commonly use this device, particularly in hospital settings.
What are the FDA-cleared indications?
The device is indicated for filtering blood products during transfusions to prevent complications from microaggregates and contaminants.